26
Participants
Start Date
October 14, 2008
Primary Completion Date
February 8, 2013
Study Completion Date
February 8, 2013
Idursulfase
Patients received idursulfase as prescribed by their physician following locally approved prescribing information. Patients will not be provided idursulfase by Shire Human Genetic Therapies, Inc. or the HOS.
Children's Hospitals and Clinics of Minnesota, Division of Genetics, Minneapolis
Children's Hospital & Research Center Oakland, Oakland
Hospital de Clinicas de Porto Alegre, Servico de Genetica Medica, Porto Alegre
Birmingham Children's Hospital, Birmingham
Great Ormond Street Hospital, London
Central Manchester University Hospitals, St. Mary's Hospital, Manchester
Lead Sponsor
Shire
INDUSTRY